All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, viral infection, Tocilizumab, Immunotherapy, Cancer patients, Anti-PD-1, Immune checkpoint inhibitors, anti-CTLA-4, anti-PD-L1, 【제목키워드】 Treatment, Immune checkpoint inhibitor, anticancer,
【저자키워드】 COVID-19, SARS-CoV-2, viral infection, Tocilizumab, Immunotherapy, Cancer patients, Anti-PD-1, Immune checkpoint inhibitors, anti-CTLA-4, anti-PD-L1, 【제목키워드】 Treatment, Immune checkpoint inhibitor, anticancer,